
US ice cream makers say they'll stop using artificial dyes by 2028
The move is the latest voluntary effort by food manufacturers to heed calls from the Trump administration to remove synthetic dyes over concerns about potential health effects. In recent weeks, companies including Nestle, Kraft Heinz and General Mills said they would pull artificial colors from their foods, too.
'This is a Renaissance moment for health in America," U.S. Food and Drug Administration Commissioner Marty Makary said at a news conference.
About 40 makers of ice cream and frozen dairy desserts said they would remove seven petroleum-based dyes from their products by 2028, according to Michael Dykes, president of the International Dairy Foods Association. The colors are Red 3, Red 40, Green 3, Blue 1, Blue 2, Yellow 5 and Yellow 6. The trade group wouldn't identify the firms, although Turkey Hill Dairy chief executive Andy Jacobs joined the gathering.
The national focus on artificial food dyes is 'a good step to take," but officials should not ignore larger known contributors to chronic disease, including the added sugars and saturated fat commonly found in ice cream, said Deanna Hoelscher, a University of Texas nutrition expert.
'Just taking out or changing the food dye source is not necessarily going to make it a healthy option,' she said. 'It still is a food that should be consumed in moderation.'
However, Makary also hinted that new federal dietary guidelines, expected later this year, would challenge established links between saturated fat and heart disease, ending what he called 'a 70-year demonization of natural saturated fat.'
The average American eats about 4 gallons of ice cream a year, the IDFA said.
Health advocates have long called for the removal of artificial dyes from foods, citing mixed studies showing that they may cause some neurobehavioral problems, such as hyperactivity and attention problems, in some children. The Food and Drug Administration has maintained that approved dyes are safe and that 'most children have no adverse effects' when consuming foods made with them.
Health Secretary Robert F. Kennedy Jr. has criticized the dyes and pressured manufacturers to remove them from foods. In their place, manufacturers should use dyes made from fruit juices, plant extracts and other sources, federal officials said.
The FDA has approved new natural color additives in recent months, including a new blue color made from the fruit of the gardenia announced Monday. Gardenia (genipin) blue is approved for use in sports drinks, candies and certain other products, the agency said.
Makary also sent a letter to food manufacturers on Monday that 'encourages' them to speed up removal of the dye known as Red 3, which was banned in January. Food makers have until 2027 to remove the dye, which was found to cause cancer in laboratory rats, but not humans.
Some food companies have said they will stop using artificial dyes, but relying on voluntary action rather than regulatory requirements won't guarantee compliance, said Thomas Galligan, a scientist with the Center for Science in the Public Interest, a consumer advocacy group.
'Talk is cheap,' Galligan said. 'It's easy for companies to make promises to look like they're being compliant and generate goodwill among consumers and the Trump administration, but it remains to be seen if they will actually follow through.'
___
The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Department of Science Education and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

USA Today
19 minutes ago
- USA Today
'A seismic change': Trump wants LGBTQ+ material axed from sex ed
The federal Teen Pregnancy Prevention Program serves more than 300,000 youth. The Trump administration is telling organizations working to prevent teen pregnancy that they must stop teaching content that doesn't align with the administration's views on transgender people and parental rights or they'll risk losing their federal funding. Seventy-three organizations – including local health departments, community groups and universities – receive a portion of the $101 million budget for the Teen Pregnancy Prevention Program each year. The groups serve more than 300,000 youth, mostly in school settings. "This is a seismic change," said Adrian Shanker, the former deputy assistant secretary for health policy under President Joe Biden. "This is a program that has been effective at keeping teens across the country from getting pregnant, so this should be a universally appreciated goal." The Department of Health and Human Services policy, announced in a July 1 memo to grantees, bans grant-funded programs from teaching about sex that is not heterosexual vaginal intercourse. It also bans 'the eroticization of birth control methods' and bans any content on creating more pleasurable sexual experiences. The policy goes on to prohibit any discussion of youth experiencing gender dysphoria or expressing transgender identities. "The statute does not require, support, or authorize teaching minors about (ideological) content, including the radical ideological claim that boys can identify as girls and vice versa," the memo to grant recipients says. "Programs must be aimed at reducing teen pregnancy, not instructing in such ideological content." Public health experts say the move could further stigmatize LGBTQ+ youth, who have higher rates of teen pregnancy than their heterosexual peers, and often feel less comfortable speaking to parents or health care providers about sex. Emily Hilliard, the press secretary for the Department of Health and Human Services, said in a statement that the new policy 'ensures that taxpayer dollars no longer support content that undermines parental rights, promotes radical gender ideology, or exposes children to sexually explicit material under the banner of public health.' Corina T. Lelutiu-Weinberger, an associate professor of health sciences research at Columbia University in New York, said teen pregnancy rates are already disproportionately high among bisexual girls, so making it harder to talk about their sexual behavior puts them at higher risk. A 2018 study published by the American Academy of Pediatrics found that bisexual girls had 'nearly five times the risk of teen pregnancy, and those who identified as mostly heterosexual or lesbian had about twice the risk compared to teens who were completely heterosexual.' Most of the disparity was explained by physical, emotional or sexual abuse. Lelutiu-Weinberger said youth tend to figure out their sexuality alone because they don't want to talk about it with their parents. She said LGBTQ+ people also tend to have a harder time talking about sex with health care providers, who often are not comfortable about talking about sex, or may have their own biases. 'There is a lot of discomfort and mislabeling and often there are no conversations,' Lelutiu-Weinberger said. 'And both parties are uncomfortable bringing it up because of fear of stigma.' Amelia Stanton, a Boston University professor and investigator for the Sexual, Reproductive and Mental Health Disparities Program, said the changes don't align with science or promote the best interest of public health. 'If we're limiting that information, we're not offering tools for planning,' Stanton said. 'We're not offering the opportunity to really learn how to prevent STIs or how to have agency in sexual activity.' Stanton said heterosexual intercourse might align more with traditional values, but failing to teach kids about oral sex, anal sex and other sexual behavior that carries risk for sexually transmitted infections will cause the rates of those infections to increase. Nearly half the nation's cases of chlamydia, gonorrhea and syphilis in 2023 were reported in people 15 to 24, according to the Centers for Disease Control. Infections were disproportionately high among men who had sex with men. Shanker, the former Biden aide, said that Congress created the Teen Pregnancy Prevention Program in 2010 under President Barack Obama to replace an abstinence-only sex education model in place under President George W. Bush. 'We have a comprehensive program that's highly effective, and they're tinkering with it for political purposes instead of trying to achieve public health results for the American people,' Shanker said.


New York Post
28 minutes ago
- New York Post
Rep. Wesley Hunt probes how many of New York's 670K illegal immigrants are on Medicaid
Texas Rep. Wesley Hunt is demanding answers from New York Gov. Kathy Hochul over how many of the state's estimated 670,000 illegal immigrants are receiving access to Medicaid benefits Hunt (R-Texas) blasted out a missive to Hochul on Monday, raising questions about how the Empire State has leveraged waivers to allow its Medicaid program to operate differently from federal standards. 'Governor Hochul is required to report this information to the federal government. So the question is simple: Will she comply, or continue to harbor lawbreakers while putting the health care of law-abiding citizens at risk?' Hunt said in a statement to The Post. 'This is what Democrat leadership looks like: open borders, benefits for illegal aliens, and betrayal of the American people.' An estimated 1.4 million people 'whose citizenship, nationality, or satisfactory immigration status is not verified' are potentially being covered by Medicaid programs in various states, according to a Congressional Budget Office estimate. 3 Rep. Wesley Hunt demanded New York investigate whether illegal immigrants have benefited from Medicaid. CQ-Roll Call, Inc via Getty Images 3 New York Gov. Kathy Hochul has ripped Republicans for cutting Medicaid in the One Big Beautiful Bill Act. Gabriella Bass One study from the liberal-leaning Fiscal Policy Institute cited by Hunt found that there are some 670,000 illegal immigrants in the Empire State — about 4% of its population. New York has benefited from Section 1115 waivers, which allow it to experiment and deviate from federal standards in its implementation of Medicaid, a program that provides health insurance to 70 million low-income Americans. Hunt noted that the Biden administration had rejected the use of those waivers for states like South Carolina, Arizona, and elsewhere. The Texas Republican stressed that the waivers were not intended to allow illegal immigrants to benefit. 'The Biden Administration allowed, and even encouraged, the use of these 1115 waivers to extend Medicaid to undocumented immigrants, despite federal law prohibiting them from receiving such benefits,' Hunt wrote in his Monday letter to Hochul. Back in February, President Trump signed an executive order directing his administration to ensure, to the maximum extent possible, that 'no taxpayer-funded benefits go to unqualified aliens.' That order pointed to existing law, such as the Personal Responsibility and Work Opportunity Reconciliation Act of 1996, which generally blocks illegal immigrants from getting federal benefits from the taxpayers. The Texas Republican also cited concerns about New York's Green Light Law, which permits all state residents, regardless of immigration status, to get driver's licenses. 3 An estimated 4% of New York's population are illegal immigrants, according to a study. Robert Mecea The Justice Department filed a lawsuit against that law, arguing it hamstrings federal enforcement of immigration law. Hunt argued it could help illegal immigrants get access to taxpayer-funded benefits. To address these concerns, Hunt demanded Hochul conduct a review of its Medicaid enrollment based on Social Security numbers and release those findings to the public. 'New Yorkers deserve transparency, accountability, and adherence to the law in the administration of public health programs,' Hunt argued in his letter to Hochul. 'Policies that divert limited resources away from lawful recipients not only violate federal standards—-they destroy public trust and threaten the sustainability of programs designed to serve our most vulnerable citizens.' The Post contacted a Hochul spokesperson for comment. Hunt has drawn speculation over recent weeks that he may vie for Sen. John Cornyn's (R-Texas) seat in the 2026 midterm cycle.
Yahoo
an hour ago
- Yahoo
Sino Biopharma spends $951m to acquire China-based LaNova Medicines
Hong Kong-listed Sino Biopharmaceutical will acquire China-based oncology specialist LaNova Medicines in a deal that will not exceed $951m, representing one of the largest transactions within the Asia-Pacific pharmaceutical arena this year. Sino already owns a 4.91% stake courtesy of an investment in November 2024, with the company now seeking to purchase the remaining 95.09% it does not own. At the time, Sino spent 142 million yuan ($19.80m) to initiate its ownership involvement with the biotech. The net payment made by Sino to acquire LaNova will be approximately $500.9m, a figure that excludes the estimated cash and bank deposits, according to a company document outlining the terms of the transaction. Following the completion of the nearly billion-dollar deal, LaNova Medicines will become an indirect wholly owned subsidiary of Sino. A timeline of 30 business days has been set by the companies to finalise the deal. Sino revealed the acquisition agreement after trading hours on 15 July. The share price in the company had climbed 3.6% by market close. LaNova's drug development focuses on tumour immunity and the tumour microenvironment. The company has particular emphasis on antibody-drug conjugates (ADCs) and has built several platforms within this modality. Sino stated the acquisition would strengthen its research and development capabilities, subsequently enhancing competitiveness and innovation in the oncology market. LaNova's pipeline has already been raided twice by US big pharma companies. In 2023, AstraZeneca licensed LM-305, a G-protein targeting-ADC, for $600m. A year later, MSD outlaid more than $3bn to secure global rights to LM-299, an anti-PD-1/VEGF bispecific antibody. According to Sino, LaNova Medicines has two projects in the registration clinical stage, six projects in the Phase I/II clinical trial stage, and more than ten projects in the preclinical research stage. In a statement, Sino said: 'Through the in-depth synergy and integration of the advantageous resources of both parties, not only will the potential value of LaNova Medicines be fully released, but also [Sino's] innovation capability will be comprehensively enhanced." The company added that the transaction will help towards its 'strategic goal of advancing towards a world-class innovative pharmaceutical enterprise'. China's economy grew 5.2% year-on-year in Q2, defying the lingering effects of US President Trump's trade war and reinforcing its position as the world's top exporter. This economic resilience is mirrored in China's growing role in the global oncology market. Despite economic pressures, licensing promising drug candidates from Chinese biotechs is becoming a well-trodden path for many US big pharma companies. Licensing deals between US and Chinese biopharma companies hit record highs last year, a 280% increase from 2020, according to analysis by GlobalData. Across big pharma, transactions rose 66% from $16.6bn in 2023 to $41.5bn in 2024, demonstrating that China is still the go-to place to discover pipeline candidates. For deals specific to US companies, the analysis found that total deal value rose from $15.7bn in 2023 to $21.3bn in 2024. GlobalData is the parent company of Pharmaceutical Technology. "Sino Biopharma spends $951m to acquire China-based LaNova Medicines" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Sign in to access your portfolio